| - GRCh37:
- Chr3:176769298-176769299
- GRCh38:
- Chr3:177051510-177051511
| TBL1XR1 | I141fs, I54fs | Intellectual disability, autosomal dominant 41, Pierpont syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr3:176755939-176756243
| TBL1XR1 | | Pierpont syndrome, Intellectual disability, autosomal dominant 41 | not provided | no assertion provided |
| - GRCh37:
- Chr3:176756100
- GRCh38:
- Chr3:177038312
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:176756187-176756189
- GRCh38:
- Chr3:177038399-177038401
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | N233del, N320del | Pierpont syndrome | Uncertain significance (May 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768417
- GRCh38:
- Chr3:177050629
| TBL1XR1 | | Pierpont syndrome | Likely benign (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750739
- GRCh38:
- Chr3:177032951
| TBL1XR1 | | Pierpont syndrome | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176752086
- GRCh38:
- Chr3:177034298
| TBL1XR1 | V297F, V384F | not provided, Pierpont syndrome | Uncertain significance (Jun 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:176744254
- GRCh38:
- Chr3:177026466
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176756226
- GRCh38:
- Chr3:177038438
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771627
- GRCh38:
- Chr3:177053839
| TBL1XR1 | | Pierpont syndrome | Likely benign (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769364
- GRCh38:
- Chr3:177051576
| TBL1XR1 | S119G, S32G | Pierpont syndrome | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771690
- GRCh38:
- Chr3:177053902
| TBL1XR1 | | Pierpont syndrome | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768277
- GRCh38:
- Chr3:177050489
| TBL1XR1 | | Pierpont syndrome | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765106
- GRCh38:
- Chr3:177047318
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Nov 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765203-176765208
- GRCh38:
- Chr3:177047415-177047420
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750831
- GRCh38:
- Chr3:177033043
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768367
- GRCh38:
- Chr3:177050579
| TBL1XR1 | | Pierpont syndrome | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176756096
- GRCh38:
- Chr3:177038308
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769368
- GRCh38:
- Chr3:177051580
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176767868
- GRCh38:
- Chr3:177050080
| TBL1XR1 | T120A, T207A | Pierpont syndrome | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769470
- GRCh38:
- Chr3:177051682
| TBL1XR1 | | Pierpont syndrome | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176752065
- GRCh38:
- Chr3:177034277
| TBL1XR1 | N391D, N304D | Pierpont syndrome | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769412
- GRCh38:
- Chr3:177051624
| TBL1XR1 | L16V, L103V | Pierpont syndrome | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765261
- GRCh38:
- Chr3:177047473
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765336
- GRCh38:
- Chr3:177047548
| TBL1XR1-AS1, TBL1XR1 | S148N, S235N | Pierpont syndrome | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765265
- GRCh38:
- Chr3:177047477
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176751996
- GRCh38:
- Chr3:177034208
| TBL1XR1 | M414L, M327L | Pierpont syndrome | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750885
- GRCh38:
- Chr3:177033097
| TBL1XR1 | D343E, D430E | Pierpont syndrome | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765194
- GRCh38:
- Chr3:177047406
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176743304
- GRCh38:
- Chr3:177025516
| TBL1XR1 | | Pierpont syndrome | Likely benign (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176744262
- GRCh38:
- Chr3:177026474
| TBL1XR1 | T473A, T386A | Pierpont syndrome | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765316
- GRCh38:
- Chr3:177047528
| TBL1XR1, TBL1XR1-AS1 | T242A, T155A | Pierpont syndrome | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765134
- GRCh38:
- Chr3:177047346
| TBL1XR1-AS1, TBL1XR1 | K186R, K273R | Pierpont syndrome | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771579
- GRCh38:
- Chr3:177053791
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765125
- GRCh38:
- Chr3:177047337
| TBL1XR1, TBL1XR1-AS1 | K276R, K189R | Pierpont syndrome | Uncertain significance (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176767930-176767931
- GRCh38:
- Chr3:177050142-177050143
| TBL1XR1 | | Pierpont syndrome | Benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176755874
- GRCh38:
- Chr3:177038086
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176767768
- GRCh38:
- Chr3:177049980
| TBL1XR1 | | Pierpont syndrome | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176755923
- GRCh38:
- Chr3:177038135
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | N275S, N362S | Pierpont syndrome | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765081
- GRCh38:
- Chr3:177047293
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176752017
- GRCh38:
- Chr3:177034229
| TBL1XR1 | N407D, N320D | Pierpont syndrome | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176755901
- GRCh38:
- Chr3:177038113
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176743294
- GRCh38:
- Chr3:177025506
| TBL1XR1 | R426W, R513W | Pierpont syndrome | Uncertain significance (Nov 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176744141
- GRCh38:
- Chr3:177026353
| TBL1XR1 | | Pierpont syndrome | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176763905
- GRCh38:
- Chr3:177046117
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176744272
- GRCh38:
- Chr3:177026484
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765341
- GRCh38:
- Chr3:177047553
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176744230
- GRCh38:
- Chr3:177026442
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768249
- GRCh38:
- Chr3:177050461
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765087
- GRCh38:
- Chr3:177047299
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely pathogenic (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176756101
- GRCh38:
- Chr3:177038313
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Uncertain significance (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769523
- GRCh38:
- Chr3:177051735
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176763983
- GRCh38:
- Chr3:177046195
| TBL1XR1-AS1, TBL1XR1 | | Pierpont syndrome | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768251
- GRCh38:
- Chr3:177050463
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765347
- GRCh38:
- Chr3:177047559
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Benign (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176763936
- GRCh38:
- Chr3:177046148
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176751969
- GRCh38:
- Chr3:177034181
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765326
- GRCh38:
- Chr3:177047538
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176744167
- GRCh38:
- Chr3:177026379
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769386
- GRCh38:
- Chr3:177051598
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176782693-176782694
- GRCh38:
- Chr3:177064905-177064906
| TBL1XR1 | | Pierpont syndrome | Likely benign (May 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750811
- GRCh38:
- Chr3:177033023
| TBL1XR1 | R368K, R455K | Pierpont syndrome | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750933
- GRCh38:
- Chr3:177033145
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176755870
- GRCh38:
- Chr3:177038082
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769461
- GRCh38:
- Chr3:177051673
| TBL1XR1 | | Pierpont syndrome | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771725-176771728
- GRCh38:
- Chr3:177053937-177053940
| TBL1XR1 | | Pierpont syndrome | Likely benign (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176756171
- GRCh38:
- Chr3:177038383
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | S239N, S326N | Pierpont syndrome | Uncertain significance (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765322
- GRCh38:
- Chr3:177047534
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176765267
- GRCh38:
- Chr3:177047479
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176751973
- GRCh38:
- Chr3:177034185
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769369
- GRCh38:
- Chr3:177051581
| TBL1XR1 | A30V, A117V | Pierpont syndrome | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771546
- GRCh38:
- Chr3:177053758
| TBL1XR1 | | Pierpont syndrome | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769478
- GRCh38:
- Chr3:177051690
| TBL1XR1 | L81V | Pierpont syndrome | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176752011
- GRCh38:
- Chr3:177034223
| TBL1XR1 | P322T, P409T | Pierpont syndrome | Uncertain significance (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771700-176771701
- GRCh38:
- Chr3:177053912-177053913
| TBL1XR1 | S22fs | Pierpont syndrome | Pathogenic (Aug 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176756211
- GRCh38:
- Chr3:177038423
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | D226N, D313N | Pierpont syndrome, Intellectual disability, autosomal dominant 41 | Likely pathogenic (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769363
- GRCh38:
- Chr3:177051575
| TBL1XR1 | S119T, S32T | Pierpont syndrome, not specified | Uncertain significance (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:176750835
- GRCh38:
- Chr3:177033047
| TBL1XR1 | S360N, S447N | Pierpont syndrome | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771646
- GRCh38:
- Chr3:177053858
| TBL1XR1 | N40S | Pierpont syndrome, not provided | Uncertain significance (Apr 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:176771720-176771721
- GRCh38:
- Chr3:177053932-177053933
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jul 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769317
- GRCh38:
- Chr3:177051529
| TBL1XR1 | | Pierpont syndrome | Likely benign (Aug 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768405
- GRCh38:
- Chr3:177050617
| TBL1XR1 | | Pierpont syndrome | Likely benign (Mar 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176767773
- GRCh38:
- Chr3:177049985
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771552
- GRCh38:
- Chr3:177053764
| TBL1XR1 | | Pierpont syndrome | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176782700
- GRCh38:
- Chr3:177064912
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769323
- GRCh38:
- Chr3:177051535
| TBL1XR1 | | Pierpont syndrome | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750931-176750934
- GRCh38:
- Chr3:177033143-177033146
| TBL1XR1 | | Pierpont syndrome | Likely benign (Dec 6, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176763904
- GRCh38:
- Chr3:177046116
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750935
- GRCh38:
- Chr3:177033147
| TBL1XR1 | | Pierpont syndrome | Likely benign (Feb 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176744173
- GRCh38:
- Chr3:177026385
| TBL1XR1 | | Pierpont syndrome | Likely benign (Jul 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176769503
- GRCh38:
- Chr3:177051715
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176756242
- GRCh38:
- Chr3:177038454
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Jan 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176763985-176763990
- GRCh38:
- Chr3:177046197-177046202
| TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176768268
- GRCh38:
- Chr3:177050480
| TBL1XR1 | | Pierpont syndrome | Likely benign (May 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176767941
- GRCh38:
- Chr3:177050153
| TBL1XR1 | | Pierpont syndrome | Likely benign (Oct 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176750939
- GRCh38:
- Chr3:177033151
| TBL1XR1 | | Pierpont syndrome | Likely benign (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176755871
- GRCh38:
- Chr3:177038083
| LOC126806878, TBL1XR1, TBL1XR1-AS1 | | Pierpont syndrome | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176767830
- GRCh38:
- Chr3:177050042
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176771541
- GRCh38:
- Chr3:177053753
| TBL1XR1 | | Pierpont syndrome | Likely benign (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:176743292
- GRCh38:
- Chr3:177025504
| TBL1XR1 | | Pierpont syndrome | Likely benign (Sep 16, 2021) | criteria provided, single submitter |